Block Copolymer Micelles in Nanomedicine Applications
Open accessThe DOI matches its Crossref record; 496 of the 496 references it cites were found in a registry or an index.
Abstract
Polymeric micelles are demonstrating high potential as nanomedicines capable of controlling the distribution and function of loaded bioactive agents in the body, effectively overcoming biological barriers, and various formulations are engaged in intensive preclinical and clinical testing. This Review focuses on polymeric micelles assembled through multimolecular interactions between block copolymers and the loaded drugs, proteins, or nucleic acids as translationable nanomedicines. The aspects involved in the design of successful micellar carriers are described in detail on the basis of the type of polymer/payload interaction, as well as the interplay of micelles with the biological interface, emphasizing on the chemistry and engineering of the block copolymers. By shaping these features, polymeric micelles have been propitious for delivering a wide range of therapeutics through effective sensing of targets in the body and adjustment of their properties in response to particular stimuli, modulating the activity of the loaded drugs at the targeted sites, even at the subcellular level. Finally, the future perspectives and imminent challenges for polymeric micelles as nanomedicines are discussed, anticipating to spur further innovations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PEG-b-PBLA block copolymer was employed to form polymeric micelles for the physical encapsulation of doxorubicin [2].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [2]
In the citing paper
“The micelle formulation exhibited 15–20% of doxorubicin loading and a 57–70 nm of size distribution.”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [2]
In the citing paper
“PEG-b-PBLA block copolymer was used to yield polymeric micelles for the physical encapsulation of doxorubicin [85]. The micelle preparation displayed 15–20% of doxorubicin loading and a 57–70 nm of size distribution.”
From Recent Advances in Nanomicelles Delivery Systems. (2020) · cites this paper as [85]
In the citing paper
“For example, micelles are suitable for the delivery of water-insoluble and amphiphilic drugs, and liposomes can increase the cellular uptake of a variety of drugs.14,15”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [15]
In the citing paper
“For example, micelles are suitable for the delivery of water-insoluble and amphiphilic drugs, and liposomes can increase the cellular uptake of a variety of drugs.14,15”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [15]
Citations
Cites
1 retracted
Elsabahy, M., Perron, M.-È., Bertrand, N., Yu, G.-E., & Leroux, J.-C. (2007) · Biomacromolecules · doi:10.1021/bm070226v · Cited by 83
RetractedNanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Photodynamic therapy for cancer
Dolmans, D. E. J. G. J., Fukumura, D., & Jain, R. K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1071 · Cited by 6,758
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Research works printed but not linked: 4
- Kabanov, 2002, Pluronic® Block Copolymers as Novel Polymer Therapeutics for Drug and Gene Delivery, J. Controlled Release, 82, 189, 10.1016/S0168-3659(02)00009-3 · DOI · Paper page
- Wiley, 2013, Transcytosis and Brain Uptake of Transferrin-Containing Nanoparticles by Tuning Avidity to Transferrin Receptor, Proc. Natl. Acad. Sci. U. S. A., 110, 8662, 10.1073/pnas.1307152110 · DOI · Paper page
- Uchida, 2013, In vivo Messenger RNA Introduction into the Central Nervous System Using Polyplex Nanomicelle, PLoS One, 8, e56220, 10.1371/journal.pone.0056220 · DOI
- Fang, 2011, The EPR Effect: Unique Features of Tumor Blood Vessels for Drug Delivery, Factors Involved, and Limitations and Augmentation of the Effect, Adv. Drug Delivery Rev., 63, 136, 10.1016/j.addr.2010.04.009 · DOI · Paper page
Cited by
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Smart nanoparticles for cancer therapy
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073
“14,15 2) Smart nanoparticles based on speci fi c materials and components of nanocarriers can respond to external and internal stimuli, such as enzyme, pH, temperature, as well as optical and magnetic regulation, etc. 3) Another embodiment of smart nanoparticles is their tumor targeting…”
BackgroundStimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics
Mi, P. (2020) · Theranostics · doi:10.7150/thno.38069 · Cited by 830
Hwang, D., Ramsey, J. D., & Kabanov, A. V. (2020) · Advanced drug delivery reviews · doi:10.1016/j.addr.2020.09.009 · Cited by 699
“Biocompatible polymers have been extensively employed in pharmaceutical science as excipients for traditional pharmaceutical formulations and more recently in nanomedicines for enhancing therapeutic outcomes of potent drugs [1,2].”
BackgroundMethodInfluentialImproving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
Martin, J. D., Cabral, H., Stylianopoulos, T., & Jain, R. K. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0308-z · Cited by 682
Self-citation
Metadata
- Authors
- Cabral, H., Miyata, K., Osada, K., & Kataoka, K.
- Affiliations
- The University of Tokyo (JP)
- Innovation Center of NanoMedicine (JP)
- Corresponding author
- Kataoka, Kazunori
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-06-29
- Volume
- 118
- Issue
- 14
- Pages
- 6844-6892
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2811501377
- Cited by
- 1,309
- References
- 494
- Citations by year
- 2026: 92 · 2025: 166 · 2024: 147 · 2023: 190 · 2022: 192 · 2021: 206 · 2020: 181 · 2019: 119 · 2018: 16
- FWCI
- 8.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Chemical Reviews (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- Funders
- Japan Agency for Medical Research and Development (16cm0106202h0001)
- Japan Society for the Promotion of Science (JP16H03179, JP25750172)
- Ministry of Education, Culture, Sports, Science and Technology (NA)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Chemistry › Organic Chemistry › Advanced Polymer Synthesis and Characterization
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- polymeric micelles, block copolymers, nanomedicine, drug delivery, stimuli-responsive drug release, targeted drug delivery, subcellular drug delivery
- MeSH terms
- Drug Carriers, Drug Compounding, Pharmaceutical Preparations, Humans, Micelles, Oligonucleotides, Polymers, Nanomedicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.